Background Cervical screening and human papillomavirus (HPV) vaccination have been
implemented in most high-income countries; however, coverage is low in low-income and …

Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Background In the next 25 years, the epidemiology of cervical cancer in England, UK, will
change: human papillomavirus (HPV) screening will be the primary test for cervical cancer …

Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …

Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Two very effective prevention strategies for cervical cancer exist–vaccination against the
human papillomavirus (HPV) and cervical screening with primary HPV testing followed by …

Background Cervical cancer incidence remains high in several Baltic, central, and eastern
European (BCEE) countries, mainly as a result of a historical absence of effective screening …

Background The incidence of cervical cancer in China is increasing rapidly. We aimed to
forecast the age-standardised incidence of cervical cancer in China up to 2100, and to …

Summary Background In 2007, Australia was one of the first countries to introduce a national
human papillomavirus (HPV) vaccination programme, and it has since achieved high …